Patents by Inventor Jon Edd

Jon Edd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9538745
    Abstract: The present invention features novel methods for the cryopreservation of mammalian cell that combine the advantages of the slow-freezing and vitrification approaches while avoiding their shortcomings. Generally, the methods include the use of a capillary tube made of a thermally conductive wall material and a thin wall such that the ratio of the thermal conductivity of the wall material to the wall thickness is at least 1,000-500,000. The solution is then exposed to temperatures equal to or less than ?80° C. and the vitrification solution containing the mammalian cells is cooled at a rate equal to or greater than 30,000-100,000,000° C./minute. The exposure of the capillary tube with a thermally conductive and thin wall allows for vitrification of the solution in the absence of ice formation. Cryoprotectants can also be added to the vitrification solution to further prevent ice formation.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: January 10, 2017
    Assignee: The General Hospital Corporation
    Inventors: Xiaoming He, Thomas L. Toth, Mehmet Toner, Jon Edd
  • Patent number: 8298222
    Abstract: A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 30, 2012
    Assignee: The Regents of the University of California
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Patent number: 8186913
    Abstract: Various systems, methods, and devices are provided for focusing particles suspended within a moving fluid into one or more localized stream lines. The system can include a substrate and at least one channel provided on the substrate having an inlet and an outlet. The system can further include a fluid moving along the channel in a laminar flow having suspended particles and a pumping element driving the laminar flow of the fluid. The fluid, the channel, and the pumping element can be configured to cause inertial forces to act on the particles and to focus the particles into one or more stream lines.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: May 29, 2012
    Assignee: The General Hospital Corporation
    Inventors: Mehmet Toner, Dino DiCarlo, Jon Edd, Daniel Irimia
  • Publication number: 20090326436
    Abstract: A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Application
    Filed: April 27, 2009
    Publication date: December 31, 2009
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Publication number: 20090305224
    Abstract: The present invention features novel methods for the cryopreservation of mammalian cell that combine the advantages of the slow-freezing and vitrification approaches while avoiding their shortcomings. Generally, the methods include the use of a capillary tube made of a thermally conductive wall material and a thin wall such that the ratio of the thermal conductivity of the wall material to the wall thickness is at least 1,000-500,000. The solution is then exposed to temperatures equal to or less than ?80° C. and the vitrification solution containing the mammalian cells is cooled at a rate equal to or greater than 30,000-100,000,000° C./minute. The exposure of the capillary tube with a thermally conductive and thin wall allows for vitrification of the solution in the absence of ice formation. Cryoprotectants can also be added to the vitrification solution to further prevent ice formation.
    Type: Application
    Filed: April 12, 2007
    Publication date: December 10, 2009
    Inventors: Xiaoming He, Thomas L. Toth, Mehmet Toner, Jon Edd
  • Publication number: 20090014360
    Abstract: Various systems, methods, and devices are provided for focusing particles suspended within a moving fluid into one or more localized stream lines. The system can include a substrate and at least one channel provided on the substrate having an inlet and an outlet. The system can further include a fluid moving along the channel in a laminar flow having suspended particles and a pumping element driving the laminar flow of the fluid. The fluid, the channel, and the pumping element can be configured to cause inertial forces to act on the particles and to focus the particles into one or more stream lines.
    Type: Application
    Filed: April 16, 2008
    Publication date: January 15, 2009
    Applicant: The General Hospital Corporation d/b/a Massachusetts General Hospital
    Inventors: Mehmet Toner, Dino DiCarlo, Jon Edd, Daniel Irimia
  • Publication number: 20050171574
    Abstract: A method for disrupting blood flow to undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of vessels supplying blood to the undesirable tissue and through the application of electrical pulses causing blood flow disruption. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Application
    Filed: December 21, 2004
    Publication date: August 4, 2005
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Publication number: 20050171523
    Abstract: A method of stopping or controlling bleeding by the placement of electrodes into or near the vicinity of vessels is disclosed. Then the application of electrical pulses causing irreversible electroporation of vessel and blood cells throughout the entire area of current flow the bleeding is stopped or controlled. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. Through the use of irreversible electroporation bleeding can be stopped or controlled without inducing thermal damage.
    Type: Application
    Filed: December 21, 2004
    Publication date: August 4, 2005
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz